Protease inhibitors – Part 3. Synthesis of non-basic thrombin inhibitors incorporating pyridinium-sulfanilylguanidine moieties at the P1 site
- 1 November 1999
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 34 (11) , 939-952
- https://doi.org/10.1016/s0223-5234(99)00115-4
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Highly Selective Mechanism-Based Thrombin Inhibitors: Structures of Thrombin and Trypsin Inhibited with Rigid Peptidyl AldehydesBiochemistry, 1998
- Cardiovascular chemotherapy: anticoagulantsCurrent Opinion in Chemical Biology, 1998
- Animal pharmacokinetics of inogatran, a low-molecular-weight thrombin inhibitor with potential use as an antithrombotic drugBiopharmaceutics & Drug Disposition, 1998
- Synthesis and Structure−Activity Relationships of Potent Thrombin Inhibitors: Piperazides of 3-AmidinophenylalanineJournal of Medicinal Chemistry, 1997
- Molecular Recognition of Protein−Ligand Complexes: Applications to Drug DesignChemical Reviews, 1997
- Serendipity meets precision: the integration of structure-based drug design and combinatorial chemistry for efficient drug discoveryStructure, 1997
- Enzyme flexibility, solvent and ‘weak’ interactions characterize thrombin–ligand interactions: implications for drug designStructure, 1996
- Synthetic Low-Molecular Weight Thrombin Inhibitors: The Ideal Antithrombotic Drug? an IntroductionJournal of Enzyme Inhibition, 1995
- Benzyloxycarbonyl-d-Phe-Pro-methoxypropylboroglycine: a novel inhibitor of thrombin with high selectivity containing a neutral side chain at the P1 positionBiochemical Journal, 1993
- Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl derivative, D-MePhe-Pro-Arg-HJournal of Medicinal Chemistry, 1990